Your Thyroid Problem Is Actually A Conversion Problem

Your thyroid makes mostly T4, and T4 is almost completely useless on its own.

That is not a flaw in the system. It is the design. T4 is a storage form, a precursor, a signal waiting to be activated. The activation happens elsewhere, in your liver, your kidneys, and your muscle tissue, through a process called peripheral conversion, which is where your body strips one iodine atom from T4 to produce T3, the hormone that actually binds to your cells and drives metabolism.

Between 70 and 90 percent of the T3 circulating in your blood right now did not come from your thyroid. It came from that conversion process happening in your peripheral tissues.

So when someone tells you they have a thyroid problem, the more precise question is: where is the breakdown? Is the thyroid not producing enough T4? Or is the body failing to convert the T4 it already has into usable T3?

Most conventional thyroid workups never ask the second question.

The standard approach is to measure something called TSH, which stands for thyroid stimulating hormone, and which is a signal your pituitary releases to tell your thyroid to produce more hormone. The logic is that if TSH is high, the pituitary is working overtime to compensate for low thyroid output, and if TSH is normal, the system is fine. That logic is sound as far as it goes, but it only describes one part of the pathway.

TSH tells you what the pituitary is asking for. It does not tell you what the tissues are actually receiving.

A 2011 study published in PLoS ONE followed patients who had their thyroids removed entirely and were placed on levothyroxine, which is synthetic T4, to replace the hormone they could no longer make. Even when their TSH was brought into the normal range, more than 20 percent of those patients still had abnormal free T3 or free T4 levels. Their pituitary was satisfied, but their cells were not getting what they needed.

That gap exists because the pituitary measures its own feedback loop, not your tissue-level hormone status. If conversion is impaired, TSH can look completely normal while free T3 is low and symptoms are very much present.

The enzyme responsible for converting T4 into T3 is called a deiodinase, and there are three types. The one called D1 is concentrated in the liver and kidneys. The one called D2 does much of the work in skeletal muscle. This distribution matters because skeletal muscle is the largest organ in the body by mass, and it is one of the primary sites where your circulating T4 gets turned into active T3. The more muscle tissue you carry, the more conversion capacity you have.

This is where exercise becomes relevant in a way that most thyroid conversations miss entirely.

A 2025 cross-sectional study in Biomolecules looked at people with Hashimoto's thyroiditis, the autoimmune form of hypothyroidism, and compared those who exercised recreationally to those who were sedentary. The exercising group showed meaningfully lower levels of inflammatory markers, including antibody levels that are the signature of the autoimmune attack on the thyroid. Exercise was not just improving how people felt. It was shifting the underlying inflammatory environment that drives the disease.

Building muscle is not just about conversion capacity, though that matters. It is about reducing the systemic inflammation that impairs conversion in the first place.

Protein is the other lever, and it operates at multiple levels simultaneously.

The deiodinase enzymes that convert T4 to T3 are called selenoproteins, meaning they require selenium to function. Selenium comes from food, primarily protein-rich animal foods. Without adequate dietary protein, you may also be limiting the raw material for the enzymes doing the conversion. A 2025 case report in Cureus documented a patient with Hashimoto's who, through a structured high-protein dietary intervention, experienced resolution of thyroid-related symptoms alongside improving antibody markers. A single case report is not a controlled trial, but the mechanism it points to is well-supported: protein supplies the amino acids and selenium-containing compounds that the conversion machinery depends on.

Cortisol is the third piece, and it works in the opposite direction.

When the body is under chronic stress, cortisol stays elevated, and elevated cortisol promotes production of something called reverse T3, which is a mirror-image form of T3 that binds to the same receptors T3 does but does not activate them. It is like a key that fits the lock but cannot turn it. Reverse T3 competes with active T3 for receptor access, and in a chronically stressed person with high cortisol, the ratio of reverse T3 to free T3 can shift enough to cause hypothyroid symptoms even when TSH looks normal. This is one reason sleep matters in this conversation. Poor sleep drives cortisol dysregulation, which drives unfavorable conversion, which suppresses cellular T3 availability without touching TSH at all.

The practical order of operations, then, is this: train consistently, eat enough protein, sleep well, get a full panel including free T3, free T4, and reverse T3, not just TSH. If you do all of that and symptoms persist, the clinical evidence suggests that adding a small amount of direct T3 rather than relying solely on T4 conversion often resolves what levothyroxine alone cannot. A 2022 study in Frontiers in Endocrinology found that women with hypothyroidism who had residual symptoms despite normal TSH on levothyroxine experienced significant quality-of-life improvements when direct T3 was added to their protocol.

But T3 supplementation is the intervention for a system you have already tried to optimize through lifestyle. It is not the starting point.

The reason this matters beyond symptom management is that T3 drives nearly everything your cells do metabolically, including protein synthesis, mitochondrial function, heart rate regulation, and, through its interaction with IGF-1 signaling, body composition itself. Low T3 at the tissue level is not just a thyroid problem. It is a whole-body slowdown that looks like aging but is actually a conversion failure that lifestyle can often reverse.

The test that most doctors run can miss this entirely. The system that creates your most active hormone lives mostly outside your thyroid. And the inputs that govern that system are, in large part, the ones you control.

---

References

1. Gullo D, Latina A, Frasca F, Le Moli R, Pellegriti G, Vigneri R. (2011). Levothyroxine Monotherapy Cannot Guarantee Euthyroidism in All Athyreotic Patients. PLoS ONE 6(8):e22552. PMC3148220.
2. Cited for: the >20% of patients with abnormal FT3 or FT4 despite normal TSH on levothyroxine.
3. Limbaugh SL, Ennessy LA, Davis KS, Allen VT. (2025). Nutrition Based, High Protein Adjunct Therapy for Hashimoto's Thyroiditis: A Case Report. Cureus 17(9):e91597. PMC12495900.
4. Cited for: protein protocol resolving Hashimoto's symptoms.
5. Vuletić M, Žnidar V, Barić Žižić A, et al. (2025). Recreational Exercise and Inflammatory Patterns in Hashimoto's Thyroiditis: Observations from a Cross Sectional Study. Biomolecules 15(11):1510. PMC12650045.
6. Cited for: exercise reducing inflammatory markers in Hashimoto's patients.
7. Bjerkreim BA, Hammerstad SS, Gulseth HL, et al. (2022). Effect of Liothyronine Treatment on Quality of Life in Female Hypothyroid Patients With Residual Symptoms on Levothyroxine Therapy. Frontiers in Endocrinology 13:816566. PMC8902821.
8. Cited for: clinical evidence that adding T3 improves quality of life in patients with residual symptoms.
9. Lindner HH. (2025). Clinical thyroidology: beyond the 1970s' TSH T4 Paradigm. Frontiers in Endocrinology 16:1529791. PMC12234311.
10. Cited for: critique of the TSH only diagnostic model. Note: single author opinion piece.
11. European Thyroid Journal. Role of hepatic deiodinases in thyroid hormone homeostasis. PMC10160546.
12. Cited for: D1 distribution in liver and kidney, D2 distribution in skeletal muscle.
13. ScienceDirect Topics. Thyroxine Deiodinase.
14. Cited for: the 70-90 percent peripheral conversion figure.
15. Pituitary Foundation. Hormone Replacement Medication Interactions.
16. Cited for: thyroid hormone status affecting IGF-1 levels.
17. American Thyroid Association Guidelines on Treatment of Hypothyroidism.
18. Cited for: current guideline recommending TSH for monitoring without routine FT3 or rT3 testing.

---

Join the free community:
Men: Iron Forge Brotherhood
Women: Powerhouse Fitness